Literature DB >> 21472413

Rapid and quantitative assessment of KSHV LANA-mediated DNA replication.

Erika De León Vázquez1, Kenneth M Kaye.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) mediates DNA replication of terminal repeat (TR) DNA to enable viral episome persistence in latently infected cells. Southern blotting is routinely used to detect LANA-replicated DNA. We developed and validated a real-time PCR assay for TR-associated DNA and compared it with Southern blot analysis. Both PCR and Southern blot detected LANA-replicated DNA, but the PCR assay was more rapid and did not require radioisotope. PCR detection at 24 and 72 hours post-transfection demonstrated rapid loss of transfected TR DNA. LANA, and to a lesser extent a moderately deficient LANA mutant, reduced the rate of DNA loss through addition of replicated TR DNA and reduction in the loss of non-replicated DNA, the latter of which is consistent with LANA's nuclear segregation function. Therefore, this work develops a rapid, sensitive, and quantitative PCR (qPCR) assay to detect KSHV LANA-replicated DNA and demonstrates that LANA reduces TR DNA loss after transfection through replication and nuclear partitioning of TR DNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472413      PMCID: PMC3145832          DOI: 10.1007/s00705-011-0985-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  35 in total

1.  Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.

Authors:  E R Leight; B Sugden
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication.

Authors:  Alexander C Garber; Jianhong Hu; Rolf Renne
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

3.  Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.

Authors:  Brenna Kelley-Clarke; Mary E Ballestas; Viswanathan Srinivasan; Andrew J Barbera; Takashi Komatsu; Te-Ana Harris; Mia Kazanjian; Kenneth M Kaye
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

Authors:  M E Ballestas; K M Kaye
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.

Authors:  T Piolot; M Tramier; M Coppey; J C Nicolas; V Marechal
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

7.  The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.

Authors:  M A Cotter; C Subramanian; E S Robertson
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

8.  Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.

Authors:  Chunghun Lim; Hekwang Sohn; Daeyoup Lee; Yousang Gwack; Joonho Choe
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.

Authors:  Rebecca L Skalsky; Jianhong Hu; Rolf Renne
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.

Authors:  Hyun Jin Kwun; Suzane Ramos da Silva; Ishita M Shah; Neil Blake; Patrick S Moore; Yuan Chang
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

View more
  9 in total

1.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

2.  Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.

Authors:  Franceline Juillard; Erika De León Vázquez; Min Tan; Shijun Li; Kenneth M Kaye
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.

Authors:  Shijun Li; Min Tan; Franceline Juillard; Rajesh Ponnusamy; Bruno Correia; J Pedro Simas; Maria A Carrondo; Colin E McVey; Kenneth M Kaye
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

4.  A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.

Authors:  Erika De León Vázquez; Franceline Juillard; Bernard Rosner; Kenneth M Kaye
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

5.  The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence.

Authors:  Erika De León Vázquez; Kenneth M Kaye
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Discovery of acylphloroglucinol-based meroterpenoid enantiomers as KSHV inhibitors from Hypericum japonicum.

Authors:  Linzhen Hu; Yanfei Liu; Yanxing Wang; Zhenzhen Wang; Jinfeng Huang; Yongbo Xue; Junjun Liu; Zhenming Liu; Yong Chen; Yonghui Zhang
Journal:  RSC Adv       Date:  2018-07-02       Impact factor: 4.036

7.  Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence.

Authors:  Qiming Sun; Toshiki Tsurimoto; Franceline Juillard; Lin Li; Shijun Li; Erika De León Vázquez; She Chen; Kenneth Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

8.  Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.

Authors:  Jungang Chen; Liangyu Jiang; Ke Lan; Xulin Chen
Journal:  Viruses       Date:  2015-05-05       Impact factor: 5.048

9.  NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.

Authors:  Fang Zhang; Deguang Liang; Xiaoxi Lin; Zhe Zou; Rui Sun; Xing Wang; Xiaozhen Liang; Kenneth M Kaye; Ke Lan
Journal:  PLoS Pathog       Date:  2019-02-27       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.